BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7638634)

  • 1. Chronic myelogenous leukemia as a model of cancer development.
    Butturini A; Gale RP
    Semin Oncol; 1995 Aug; 22(4):374-9. PubMed ID: 7638634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
    Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukaemia as a model of disease evolution in human cancer.
    Melo JV; Barnes DJ
    Nat Rev Cancer; 2007 Jun; 7(6):441-53. PubMed ID: 17522713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
    Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F
    Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage switch from acute myeloid leukemia to biphenotypic acute leukemia with acquisition of Philadelphia chromosome.
    Lee HR; Kang SH; Kang HJ; Shin HY; Ahn HS; Kim HK; Park MH; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2008 Jul; 184(2):124-6. PubMed ID: 18617064
    [No Abstract]   [Full Text] [Related]  

  • 10. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cryptococcal cerebrospinal meningitis as a complication of acute blast crisis of chronic myeloid leukemia].
    Nowicka J; Gola A; Walów B; Koprowska-Adamczyk G
    Pol Tyg Lek; 1988 Jun; 43(23):746-7. PubMed ID: 3237514
    [No Abstract]   [Full Text] [Related]  

  • 12. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
    Nakase K; Kita K; Kyo T; Katayama N
    Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
    [No Abstract]   [Full Text] [Related]  

  • 13. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Existence and significance of T-lymphoid crisis of chronic myeloid leukemia].
    Kuriyama K
    Rinsho Ketsueki; 1990 May; 31(5):625-32. PubMed ID: 2203919
    [No Abstract]   [Full Text] [Related]  

  • 17. Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.
    Melo JV; Deininger MW
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):545-68, vii-viii. PubMed ID: 15271392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
    Wodarz D
    Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way.
    Strout MP; Schatz DG
    Cancer Cell; 2009 Sep; 16(3):174-6. PubMed ID: 19732715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.